Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen, +239

The Lancet

Platinum–etoposide Versus Platinum–etoposideMedicinePharmacologyImmune Checkpoint InhibitorFirst-line Treatment +4

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen, +247

The Lancet Oncology

Platinum–etoposide Versus Platinum–etoposideMedicinePathologyImmune Checkpoint InhibitorFirst-line Treatment +4

UV Filters with Antagonistic Action at Androgen Receptors in the MDA-kb2 Cell Transcriptional-Activation Assay

Rui Ma

Toxicological Sciences

Comparative characterization of mesenchymal stem cells from human dental pulp and adipose tissue for bone regeneration potential

Qiaoqiao Jin, Keyong Yuan, Wen-Zhen Lin, +3

Artificial Cells Nanomedicine and Biotechnology

Tissue EngineeringEngineeringBone Tissue EngineeringAdult Stem CellBone Repair +22

The decapeptide CMS001 enhances swimming endurance in mice

Huali Zhang, Rong Lu, Yanjiao Zhou, +5

Peptides

Physiological ResearchMolecular NeuroscienceMolecular PhysiologyPhysiologyMedicine +3

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML

Yue Sheng, Chunjie Yu, Yin Liu, +9

Nature Communications

Whole-body adipose tissue multi-omic analyses in sheep reveal molecular mechanisms underlying local adaptation to extreme environments

Yaxi Xu, Bo Wang, Jia-Nan Jing, +9

Communications Biology

D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results

Ziming Li, Zhengbo Song, Yanqiu Zhao, +23

Journal of Thoracic Oncology

Novel TherapyPharmacologySelective InhibitorPharmacotherapyMedicine +4

Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients

Xiaojing Xu, Huayi Ren, Boting Zhou, +5

Lung Cancer

MedicinePathologyCancer GenomicsBronchial NeoplasmLung Cancer +4

Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non‐small cell lung carcinoma patients

Xiaojing Xu, Li Duan, Boting Zhou, +3

Clinical and Experimental Pharmacology and Physiology

GeneticsPathologyTumor BiologyPlatinum ResistanceGenetic Polymorphism +14